During the past decade, Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Seagen Inc." with 3 trials sponsored, "Incyte Corporation" with 2 trials sponsored and "AnGes USA, Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika" #1 collaborator was "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator, "Janssen Research & Development, LLC" with 1 trials as a collaborator, "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator and "Kyowa Kirin, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika" are "Acute Myeloid Leukemia" (2 trials), "Disease, Hodgkin" (2 trials), "Marginal Zone Lymphoma" (2 trials), "Chronic Myelomonocytic Leukemia" (1 trials) and "Critical Limb Ischemia" (1 trials). Many other conditions were trialed in "Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika" in a lesser frequency.

Most popular intervention types in "Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika" are "Drug" (14 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (3 trials), "Tirzepatide" (2 trials), "azacitidine" (2 trials), "brentuximab vedotin" (2 trials) and "33A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".